glp-1 agonist drugs for weight loss medications GLP 1s for Weight Loss

GLP-1 drugs like Ozempic have transformed weight management, but concerns around muscle loss, bone density, dampened desire, and dependency are growing

Effectiveness and Impact Significant Weight Loss: Phase 2 studies showed up to roughly 20% average body weight loss at 52 weeks in participants with obesity

Next up: glucagon-like peptide 1 receptor agonists, known colloquially (and identified here) as GLPs

SAN DIEGO(March 10, 2025)Glucagon-like peptide-1 receptor agonists (GLP-1 agonists), such as semaglutide (e.g., Ozempic), have helped improve the management of type 2 diabetes and obesity

GLP-1 medications such as Ozempic may help lower the risk of certain cancers.